266 related articles for article (PubMed ID: 29169370)
1. Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop.
Thakur B; Ray P
J Exp Clin Cancer Res; 2017 Nov; 36(1):164. PubMed ID: 29169370
[TBL] [Abstract][Full Text] [Related]
2. p53 Loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance.
Thakur B; Ray P
Mol Oncol; 2016 Oct; 10(8):1283-95. PubMed ID: 27401370
[TBL] [Abstract][Full Text] [Related]
3. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB
Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma.
Chen X; Cao Y; Sedhom W; Lu L; Liu Y; Wang H; Oka M; Bornstein S; Said S; Song J; Lu SL
Mol Oncol; 2020 Jan; 14(1):139-158. PubMed ID: 31600013
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin induces stemness in ovarian cancer.
Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O
Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
7. KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma.
Wang B; Jing T; Jin W; Chen J; Wu C; Wang M; Liu Y
J Exp Clin Cancer Res; 2020 Aug; 39(1):170. PubMed ID: 32854746
[TBL] [Abstract][Full Text] [Related]
8. miR‑10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway.
Huang T; Ren K; Ding G; Yang L; Wen Y; Peng B; Wang G; Wang Z
Oncol Rep; 2020 Jun; 43(6):1906-1914. PubMed ID: 32186774
[TBL] [Abstract][Full Text] [Related]
9. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells.
Kim SB; Kim JS; Lee JH; Yoon WJ; Lee DS; Ko MS; Kwon BS; Choi DH; Cho HR; Lee BJ; Chung DK; Lee HW; Park JW
FEBS Lett; 2006 Jan; 580(1):311-8. PubMed ID: 16376337
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP
Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350
[TBL] [Abstract][Full Text] [Related]
12. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
[TBL] [Abstract][Full Text] [Related]
13. NF-κB-regulated miR-155, via repression of QKI, contributes to the acquisition of CSC-like phenotype during the neoplastic transformation of hepatic cells induced by arsenite.
Chen C; Luo F; Yang Q; Wang D; Yang P; Xue J; Dai X; Liu X; Xu H; Lu J; Zhang A; Liu Q
Mol Carcinog; 2018 Apr; 57(4):483-493. PubMed ID: 29240254
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H
J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D
J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of OLR1 expression by TBC1D3 through activation of TNFα/NF-κB pathway promotes the migration of human breast cancer cells.
Wang B; Zhao H; Zhao L; Zhang Y; Wan Q; Shen Y; Bu X; Wan M; Shen C
Cancer Lett; 2017 Nov; 408():60-70. PubMed ID: 28844714
[TBL] [Abstract][Full Text] [Related]
17. An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population.
Singh RK; Dhadve A; Sakpal A; De A; Ray P
Sci Rep; 2016 Nov; 6():36612. PubMed ID: 27819360
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFα-induced apoptosis.
Lee JH; Kang MJ; Han HY; Lee MG; Jeong SI; Ryu BK; Ha TK; Her NG; Han J; Park SJ; Lee KY; Kim HJ; Chi SG
Clin Cancer Res; 2011 Dec; 17(24):7551-62. PubMed ID: 21980136
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
[TBL] [Abstract][Full Text] [Related]
20. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.
Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B
Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
